Marshall Wace
AGTC

Marshall Wace’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Marshall Wace’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-20,411
Closed -$61K – 4480
2021
Q3 		$61K Buy
+20,411
New +$72.7K ﹤0.01% 2928
2020
Q1 		– Sell
-80,906
Closed -$366K – 2196
2019
Q4 		$366K Sell
80,906
-57,788
-42% -$183K ﹤0.01% 1233
2019
Q3 		$577K Buy
+138,694
New +$501K ﹤0.01% 1070
2016
Q1 		– Sell
-19,425
Closed -$396K – 1232
2015
Q4 		$396K Buy
+19,425
New +$300K ﹤0.01% 842

Other funds holding AGTC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.72B AUM 7.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Marshall Wace's AGTC Position: Q4 2021 in Review

Marshall Wace sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2021, closing a stake of 20,411 shares — an estimated $61K sold.

Marshall Wace first reported a position in AGTC in Q4 2015 and held it in 4 quarters. The position peaked at $577K in Q3 2019. 55 funds tracked by Wall St. Rank hold AGTC as of Q4 2021.

  • Marshall Wace reported no remaining Applied Genetic Technologies Corporation position as of Q4 2021 after selling out during the quarter.
  • Marshall Wace sold 20,411 Applied Genetic Technologies Corporation shares in Q4 2021, an estimated $61K.
  • Marshall Wace first reported a position in Applied Genetic Technologies Corporation in Q4 2015 and held it in 4 quarters.
  • Marshall Wace's Applied Genetic Technologies Corporation position peaked at $577K in Q3 2019.
  • 55 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2021.

Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.